Nutritional effects of oral zinc supplementation in cirrhosis

Nutrition Research

Volumn 20, Issue 8, 2000, Pages 1079-1089

  Bianchi, G P ^a,b   Marchesini, G ^a   Brizi, Mara ^a   Rossi, Brunella ^a   Forlani, G ^a   Boni, Paola ^b   Melchionda, N ^a   Thomaseth, K ^c   Pacini, G ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Istituto di Ingeneria Biomedica del CNR   (Italy)

Author keywords

Glucose Effectiveness; Insulin like Growth Factor 1; Prealbumin; Retinol binding protein; Urinary creatinine

Indexed keywords

ALBUMIN; CREATININE; GALACTOSE; GLUCOSE; PHENAZONE; PREALBUMIN; RETINOL BINDING PROTEIN; SOMATOMEDIN C; ZINC SULFATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIET SUPPLEMENTATION; FEMALE; GLUCOSE METABOLISM; HUMAN; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL;

EID: 0033839690     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(00)00194-9     Document Type: Article

References (43)

1. Trace metals in liver disease
2. Trace elements and chronic liver diseases
3. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laennec's cirrhosis and their validation by sequential analysis
4. Reduced leucocyte zinc in liver disease
5. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis
6. Short-term oral zinc supplementation does not improve chronic hepatic encephalothy. Results of a double-blind crossover trial
7. Zinc supplementation and amino-acid nitrogen metabolism in patients with advanced cirrhosis
8. Zinc supplementation in alcoholic cirrhosis
9. Zinc deficiency and anorexia in rats. Normal feeding pattern and stress induced feeding
10. Decreased taste and smell acuity in cirrhosis
11. Nutritional status in cirrhosis
12. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis
13. Insulin-like effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozotocin-induced rats
14. Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans
15. Zinc supplementation improves glucose disposal in patients with cirrhosis
16. Measurement of total body and extracellular water in cirrhotic patients with and without ascites
17. ESPEN guidelines for nutrition in liver disease and transplantation
18. Use of plasma somatomedin C /insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients
19. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with cirrhosis
20. Transection of the oesophagus for bleeding oesophageal varices
21. Toward physiological understanding of glucose tolerance minimal-model approach
22. Multiple range test for correlated and heteroscedastic means
23. Zinc: The biology and therapeutics of an ion
24. Zinc supplementation in young children with acute diarrhea in India
25. Overt hepatic encephalopathy precipitated by zinc deficiency
26. 2+ regulation of ornithine transcarbamoylase. I. Mechanism of action
27. Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats
28. The validity of the creatinine approach to estimate muscle mass in patients with liver cirrhosis
29. Nutritional regulation of insulin-like growth factor-I
30. The interaction of insulin like growth factor I (IGF I) with protein-calorie malnutrition in patients with alcoholic liver disease
31. Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women
32. Zinc supplementation increases growth factor I (IGF-1) in growth-retarded Vietnamese children
33. The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes
34. Somatomedin-C and zinc status in rats as affected by Zn, protein and food intake
35. Serum growth hormone-binding protein, insulin-like growth factor-1 and growth hormone in patients with liver cirrhosis
36. Concentration, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-1, and growth hormone in different vascular beds in patients with cirrhosis
37. Insulin-like growth factor/somatomedins structure, secretion, biological actions and physiological role
38. 125I]insulin to the plasma membrane and its relation to insulin bioactivity
39. Therapeutic potential of insulin-like growth factor I
40. Glucose disposal, b-cell secretion, and hepatic insulin extraction in liver cirrhosis. A minimal model assessment
41. Treatment with a somatostatin analog decreases pancreatic β-cell and whole body sensitivity to glucose
42. The zinc sandwich and growth
43. Zinc supplementation, copper and total antioxidant capacity in cirrhosis